ARNTL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.365800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.500400E-01
Normal-vs-Stage2
1.009410E-01
Normal-vs-Stage3
2.441400E-01
Normal-vs-Stage4
1.014230E-01
Stage1-vs-Stage2
6.605800E-01
Stage1-vs-Stage3
6.739600E-01
Stage1-vs-Stage4
5.442000E-01
Stage2-vs-Stage3
8.019000E-01
Stage2-vs-Stage4
7.028000E-01
Stage3-vs-Stage4
9.161800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.093800E-02
Normal-vs-AfricanAmerican
9.440200E-01
Normal-vs-Asian
3.482500E-03
Caucasian-vs-AfricanAmerican
3.447200E-01
Caucasian-vs-Asian
8.015600E-03
AfricanAmerican-vs-Asian
1.626450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.511000E-01
Normal-vs-Female
2.061200E-03
Male-vs-Female
1.539760E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.138000E-01
Normal-vs-Age(41-60Yrs)
2.053400E-01
Normal-vs-Age(61-80Yrs)
5.647900E-02
Normal-vs-Age(81-100Yrs)
2.556600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.989400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.687600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.964800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.083380E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.888200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.812800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.119500E-02
Normal-vs-Daily Drinker
8.118100E-02
Normal-vs-Weekly Drinker
1.025830E-02
Normal-vs-Occasional Drinker
9.142000E-03
Normal-vs-Social Drinker
2.160000E-01
Non Drinker-vs-Daily Drinker
9.759000E-01
Non Drinker-vs-Weekly Drinker
5.262200E-01
Non Drinker-vs-Occasional Drinker
8.159800E-01
Non Drinker-vs-Social Drinker
7.270800E-01
Daily Drinker-vs-Weekly Drinker
5.850600E-01
Daily Drinker-vs-Occasional Drinker
8.173000E-01
Daily Drinker-vs-Social Drinker
8.095000E-01
Weekly Drinker-vs-Occasional Drinker
6.306000E-01
Weekly Drinker-vs-Social Drinker
2.748000E-01
Occasional Drinker-vs-Social Drinker
5.312600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.946630E-01
Normal-vs-Grade 2
8.096200E-02
Normal-vs-Grade 3
1.694350E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.911600E-01
Grade 1-vs-Grade 3
3.876200E-01
Grade 1-vs-Grade 4
1.946630E-01
Grade 2-vs-Grade 3
8.245400E-01
Grade 2-vs-Grade 4
8.096200E-02
Grade 3-vs-Grade 4
1.694350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.070200E-02
Normal-vs-NonDiabetic
1.580130E-02
Diabetic-vs-NonDiabetic
8.417200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.521700E-02
Normal-vs-NoPancreatitis
9.464600E-03
Pancreatitis-vs-NoPancreatitis
5.691800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.381600E-02
Normal-vs-N1
1.171220E-01
N0-vs-N1
9.856000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.832760E-01
Normal-vs-TP53-NonMutant
3.001400E-01
TP53-Mutant-vs-TP53-NonMutant
3.557200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
